Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Otonomy
Biotech
Otonomy shuts shop, lays off employees after string of failures
The biotech has experienced a series of clinical failures throughout but kept the faith in its ear disorder pipeline until now.
James Waldron
Dec 20, 2022 7:40am
Otonomy's phase 2 backup plan fails, prompting new options
Oct 13, 2022 11:05am
Otonomy cuts lead asset loose after phase 2 failure to save cash
Aug 1, 2022 10:23am
Otonomy eyes clinical trial of hearing loss gene therapy
May 14, 2021 9:35am
Otonomy fails phase 3, adding another twist to ear disease saga
Feb 22, 2021 8:50am
Otonomy’s renaissance starts as Ménière’s disease drug clears trial
Nov 9, 2017 9:20am
